Yingmiao Liu Selected Research

lenvatinib

1/2022

Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingmiao Liu Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 01/2006
10	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 01/2010
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2022
2	Hypoxia (Hypoxemia) 01/2022 - 01/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2020
2	Hemorrhage 01/2021 - 10/2020
2	Thrombosis (Thrombus) 01/2021 - 02/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2009
2	Kidney Neoplasms (Kidney Cancer) 01/2020 - 01/2019
2	Carcinogenesis 01/2020 - 01/2009
2	Colonic Neoplasms (Colon Cancer) 03/2013 - 01/2010
2	Adenocarcinoma of Lung 08/2007 - 01/2006
1	Periodontitis 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Adenocarcinoma 01/2022
1	Thromboembolism 01/2021
1	Familial cerebral cavernous malformation 01/2021
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2021
1	Hereditary Hemorrhagic Telangiectasia 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Vascular Malformations 01/2021
1	Colitis 02/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Disease Progression 01/2020
1	Squamous Cell Carcinoma of Head and Neck 07/2019
1	Multiple Myeloma 06/2018
1	Polyps 12/2017
1	Medulloblastoma 09/2017
1	Craniocerebral Trauma (Head Injury) 02/2017
1	Choroidal Neovascularization 10/2014

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 03/2022 - 04/2013
8	Bevacizumab (Avastin)FDA Link 01/2022 - 04/2013
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2007
7	EndoglinIBA 01/2021 - 06/2014
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2009
6	carotuximabIBA 01/2021 - 06/2014
5	Nucleotide AptamersIBA 01/2010 - 08/2007
4	CytokinesIBA 01/2022 - 07/2019
4	PhosphatidylserinesIBA 01/2022 - 06/2018
4	regorafenibIBA 01/2022 - 10/2019
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
3	Monoclonal AntibodiesIBA 01/2021 - 01/2019
3	NF-kappa B (NF-kB)IBA 01/2008 - 01/2006
2	Capecitabine (Xeloda)FDA Link 01/2022 - 04/2013
2	Angiopoietin-2IBA 01/2022 - 01/2022
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022 - 01/2022
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2022
2	Fibrinogen (Factor I)FDA Link 01/2021 - 10/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2008
2	Axitinib (AG 013736)IBA 01/2021 - 01/2019
2	Glycoproteins (Glycoprotein)IBA 10/2014 - 02/2009
1	cabozantinibIBA 03/2022
1	Panitumumab (Vectibix)FDA Link 03/2022
1	prothrombinase complexIBA 01/2022
1	lenvatinibIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	inhibin AIBA 01/2022
1	Activins (Activin)IBA 01/2022
1	Inhibins (Inhibin)IBA 01/2022
1	LigandsIBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	((3- (bis(2- chloroethyl)amino)- 4- methylphenyl)hydroxymethane)bisphosphonic acidIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2020
1	Neutralizing AntibodiesIBA 12/2020
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	adhesion receptorIBA 10/2020
1	Deoxyribonucleases (DNase)FDA Link 02/2020
1	SodiumIBA 02/2020
1	Drinking WaterIBA 02/2020
1	Dextrans (Dextran)FDA Link 02/2020
1	durvalumabIBA 01/2020
1	olaparibIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	AntibodiesIBA 01/2020
1	PlatinumIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Activin Receptors (Activin Receptor)IBA 10/2019
1	ascrinvacumabIBA 10/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2018
1	Immunomodulating AgentsIBA 06/2018
1	Adenosine Triphosphate (ATP)IBA 12/2017
1	EnzymesIBA 12/2017
1	Cytidine Diphosphate Choline (Citicoline)IBA 02/2017
1	Everolimus FDA Link 04/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2013
1	IntegrinsIBA 03/2013

Therapy/Procedure

8	Therapeutics 01/2022 - 02/2009
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
2	Neoadjuvant Therapy 01/2022 - 01/2021
1	Radiotherapy 01/2022
1	Adjuvant Chemotherapy 01/2022
1	Intravenous Injections 01/2021